In the news logo featuring photos of Medtronic's 7 day infusion set, Twitter and Eli Lilly Logos, and Dexcom's G7 system including phone and watch

In the News… Teplizumab approved, Twitter mess for Lilly, Medtronic 7-day infusion set launches, and more!

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/25056099/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_528_Final_In_the_News_v2.mp3″ libsyn_item_id=”25056099″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /]It’s in the News.. the top diabetes stories of the past seven days. This week, the first drug to prevent T1D for any length of time is approved, Eli Lilly takes a financial hit from a Twitter impersonation stunt, Medtronic’s…

Provention Bio logo and child and doctor

Delaying a T1D Diagnosis? The FDA Considers Teplizumab

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/18400304/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_363_Final_Provention_Anhalt_FDA.mp3″ libsyn_item_id=”18400304″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /] The very first treatment to prevent type 1 diabetes for any length of time is in front of the FDA right now. Teplizumab has been show to prevent the onset of type 1 diabetes in people shown to be…

In the News… Does food-as-medicine work for T2D? Fake Ozempic warning, new Tzield research, My Cause My Cleats and more!

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/29259028/height/120/theme/custom/thumbnail/no/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/DC1_Ep_614_FInal_In_the_News.mp3″ libsyn_item_id=”29259028″ height=”120″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”” use_download_link=”use_download_link” download_link_text=”Download” /]It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a new study looks at food-as-medicine for type 2, another FDA warning about fake Ozempic, new research says…

In the News.. Arthritis drug studied for T1D, calls to poison control over Ozempic, Tandem Source released, and more!

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/29097458/height/120/theme/custom/thumbnail/no/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/DC1_Ep_612_Final_In_the_News_V2.mp3″ libsyn_item_id=”29097458″ height=”120″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”” use_download_link=”use_download_link” download_link_text=”Download” /]It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: an existing drug for arthritis is being studied for treatment of T1D, poison control centers report a big…

Dr. Bryce Nelson stands with teenage patient William, both wearing masks

“I want to make this a priority” – A doctor’s perspective on Tzield

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/26498673/height/360/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/26a9e0/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_558_Final_Tzield_Nelson.mp3″ libsyn_item_id=”26498673″ height=”360″ theme=”custom” custom_color=”26a9e0″ player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /]Dr. Bryce Nelson is one of the first doctors in the country to administer the new Tzield to delay the onset of type 1. He’s been involved with TrialNet, identifying those who have the genetic markets for T1D and says…

In the news logo featuring a bottle of verapamil pills, an older woman scans her sensor with a cell phone, Libre 3 system displayed

In the News.. Insulin price update, Libre approved for AID systems, Medicare expands CGM coverage and more!

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/26182449/height/360/theme/custom/thumbnail/no/direction/forward/render-playlist/no/custom-color/26a9e0/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_552_Final_V2_In_the_News.mp3″ libsyn_item_id=”26182449″ height=”360″ theme=”custom” custom_color=”26a9e0″ player_use_thumbnail=”” use_download_link=”use_download_link” download_link_text=”Download” /]It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: learning more about Lilly’s plan to lower the price of some insulins, Abbott’s Libre 2 and Libre 3…

William Troutman in a hospital chair receives IV treatment. He holds up seven fingers to mark his seventh day of treatment.

Delaying a T1D diagnosis with Tzield: “A deep sigh of relief, for a little while”

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/26140521/height/360/theme/custom/thumbnail/no/direction/forward/render-playlist/no/custom-color/26a9e0/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_551_Final_Tzield_Troutman.mp3″ libsyn_item_id=”26140521″ height=”360″ theme=”custom” custom_color=”26a9e0″ player_use_thumbnail=”” use_download_link=”use_download_link” download_link_text=”Download” /]Last fall, Tzield was approved to delay type 1 diabetes in people predicted to develop it. This week, I’m talking one of the first families to use what used to be called Teplizumab for their son, as a regular patient,…

In the News logo featuring photos of pro soccer player Jordan Morris in uniform, a vial of Tzield medication and the Ypsomed pump

In the News… AID using Libre 3, Tzield cost, protein trigger research for T1D and more!

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/25188333/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_531_Final_In_the_News.mp3″ libsyn_item_id=”25188333″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /]It’s In the News.. a roundup of the top diabetes stories and headlines of the past seven days. This week: the first AID system to use Libre 3 is released, we learn more about Teplizumab, now brand name Tzield, to…

In the new logo with photos of generic looking vials, the Libre CGM and three men in the 50s playing basketball

In the News.. A partner for a T1D prevention drug, expanding CGM Medicare coverage, the worst age for T2D outcomes, and more!

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/24681774/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_519_Final_In_the_News.mp3″ libsyn_item_id=”24681774″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /]It’s It’s “In the News…” a look at the top diabetes stories and headlines of the past seven days. This week: Provention Bio hopes to get FDA approval of Teplizumab next month and partners with Sanofi on this T1D prevention…

In the news logo

In the News.. Nanoparticles T1D study, Oral insulin tested for T2D, a type 1 Squishmallow and more!

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/23092337/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_477_Final_In_the_news.mp3″ libsyn_item_id=”23092337″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /]It’s “In the News…” Got a few minutes? Get caught up! Top stories this week: racial disparities in treatment for kids with type 1, new study looks at oral insulin for type 2, nanoparticles tested to prevent diabetes and why…